轻度自主皮质醇分泌患者的衰弱程度高于无功能肾上腺肿瘤患者
该回顾性研究(2003-2018年)在转诊中心比较了轻度自主皮质醇分泌(MACS)患者与无功能肾上腺肿瘤(NFAT)患者的衰弱情况。MACS患者(n=168)的年龄、性别和体重指数校正后衰弱指数高于NFAT患者(n=275)(0.17 vs 0.15;P=0.009),且合并症和不良症状负担更重。
要点
- MACS患者年龄、性别和BMI校正后衰弱指数高于NFAT患者(0.17 vs 0.15;P=0.009)。
- 以衰弱指数0.25为切点,MACS患者衰弱比例为24%,NFAT患者为18%(P=0.028)。
- MACS患者高血压、心律失常、慢性肾脏病及乏力、跌倒、睡眠困难症状均多于NFAT患者。
核心结论
- MACS患者较NFAT患者表现出更高的合并症负担、不良症状和衰弱程度。
- 未来需前瞻性研究进一步描述衰弱特征、评估其对肾上腺切除术的反应性及其对健康结局的影响。
研究设计与样本
- 回顾性研究,时间范围为2003年至2018年,在转诊中心进行。
- 纳入年龄大于20岁的肾上腺腺瘤患者,MACS定义为1 mg过夜地塞米松抑制试验(DST)后皮质醇1.9-5 µg/dL,NFAT定义为DST后皮质醇<1.9 µg/dL。
- MACS组168例,NFAT组275例。
- 主要结局指标为采用47项缺陷模型计算的衰弱指数(范围0-1)。
主要发现
- MACS组与NFAT组年龄、性别和体重指数校正后高血压患病率分别为71% vs 60%,心律失常为50% vs 40%,慢性肾脏病为25% vs 17%,哮喘为5% vs 14%。
- MACS组与NFAT组乏力症状分别为21% vs 11%,跌倒为7% vs 2%,睡眠困难为26% vs 15%。
- MACS组年龄、性别和BMI校正后衰弱指数高于NFAT组(0.17 vs 0.15;P=0.009)。
- 以衰弱指数0.25为切点,MACS组衰弱比例为24%,NFAT组为18%(P=0.028)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Mild autonomous cortisol secretion (MACS) affects up to 50% of patients with adrenal adenomas. Frailty is a syndrome characterized by the loss of physiological reserves and an increase in vulnerability, and it serves as a marker of declining health. OBJECTIVE: To compare frailty in patients with MACS versus patients with nonfunctioning adrenal tumors (NFAT). DESIGN: Retrospective study, 2003-2018. SETTING: Referral center. PATIENTS: Patients >20 years of age with adrenal adenoma and MACS (1 mg overnight dexamethasone suppression (DST) of 1.9-5 µg/dL) and NFAT (DST <1.9 µg/dL). MAIN OUTCOME MEASURE: Frailty index (range 0-1), calculated using a 47-variable deficit model. RESULTS: Patients with MACS (n = 168) demonstrated a higher age-, sex-, and body mass index-adjusted prevalence of hypertension (71% vs 60%), cardiac arrhythmias (50% vs 40%), and chronic kidney disease (25% vs 17%), but a lower prevalence of asthma (5% vs 14%) than patients with NFAT (n = 275). Patients with MACS reported more symptoms of weakness (21% vs 11%), falls (7% vs 2%), and sleep difficulty (26% vs 15%) as compared with NFAT. Age-, sex- and BMI-adjusted frailty index was higher in patients with MACS vs patients with NFAT (0.17 vs 0.15; P = 0.009). Using a frailty index cutoff of 0.25, 24% of patients with MACS were frail, versus 18% of patients with NFAT (P = 0.028). CONCLUSION: Patients with MACS exhibit a greater burden of comorbid conditions, adverse symptoms, and frailty than patients with NFAT. Future prospective studies are needed to further characterize frailty, examine its responsiveness to adrenalectomy, and assess its influence on health outcomes in patients with MACS.
引用
- Singh S, Atkinson EJ, Achenbach SJ, et al. Frailty in Patients With Mild Autonomous Cortisol Secretion is Higher Than in Patients with Nonfunctioning Adrenal Tumors. J Clin Endocrinol Metab. 2020. PMID: 32628749. doi:10.1210/clinem/dgaa410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。